PL3259598T3 - Wielofunkcyjne magneto-polimeryczne nanosystemy do szybkiego celowania w krążące komórki nowotworowe, ich izolacji, wykrywania i jednoczesnego obrazowania - Google Patents

Wielofunkcyjne magneto-polimeryczne nanosystemy do szybkiego celowania w krążące komórki nowotworowe, ich izolacji, wykrywania i jednoczesnego obrazowania

Info

Publication number
PL3259598T3
PL3259598T3 PL16752004T PL16752004T PL3259598T3 PL 3259598 T3 PL3259598 T3 PL 3259598T3 PL 16752004 T PL16752004 T PL 16752004T PL 16752004 T PL16752004 T PL 16752004T PL 3259598 T3 PL3259598 T3 PL 3259598T3
Authority
PL
Poland
Prior art keywords
magneto
multifunctional
isolation
detection
tumor cells
Prior art date
Application number
PL16752004T
Other languages
English (en)
Inventor
Jayant Jagannath Khandare
Shashwat BANERJEE
Muralidhara Padigaru
Ganesh KHUTALE
Original Assignee
Actorius Innovations And Research Pvt. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actorius Innovations And Research Pvt. Ltd. filed Critical Actorius Innovations And Research Pvt. Ltd.
Publication of PL3259598T3 publication Critical patent/PL3259598T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
    • G01N21/359—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
PL16752004T 2015-02-19 2016-02-15 Wielofunkcyjne magneto-polimeryczne nanosystemy do szybkiego celowania w krążące komórki nowotworowe, ich izolacji, wykrywania i jednoczesnego obrazowania PL3259598T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN538MU2015 2015-02-19
PCT/IB2016/050779 WO2016132265A2 (en) 2015-02-19 2016-02-15 Multifunctional magneto-polymeric nanosystems for rapid targeting, isolation, detection and simultaneous imaging of circulating tumor cells
EP16752004.8A EP3259598B1 (en) 2015-02-19 2016-02-15 Multifunctional magneto-polymeric nanosystems for rapid targeting, isolation, detection and simultaneous imaging of circulating tumor cells

Publications (1)

Publication Number Publication Date
PL3259598T3 true PL3259598T3 (pl) 2021-03-08

Family

ID=56688724

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16752004T PL3259598T3 (pl) 2015-02-19 2016-02-15 Wielofunkcyjne magneto-polimeryczne nanosystemy do szybkiego celowania w krążące komórki nowotworowe, ich izolacji, wykrywania i jednoczesnego obrazowania

Country Status (7)

Country Link
US (2) US20180024135A1 (pl)
EP (1) EP3259598B1 (pl)
CA (1) CA2976614A1 (pl)
CY (1) CY1123652T1 (pl)
ES (1) ES2828025T3 (pl)
PL (1) PL3259598T3 (pl)
WO (1) WO2016132265A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106824129B (zh) * 2017-02-15 2019-06-14 南昌航空大学 一种可分级回收Pb2+和4-NP的吸附剂的制备方法
EP3533472A1 (en) * 2018-03-02 2019-09-04 Universität Zürich Bioconjugates of antibodies and functionalized magnetic nanoparticles
CN109125725B (zh) * 2018-09-03 2021-04-02 浙江理工大学 一种具有磁靶向性的缓释可控光热-磁热-抗癌药物协同作用纳米微粒的制备方法
CN109682967B (zh) * 2018-12-17 2021-12-28 暨南大学 Pamam在制备用于免疫检测的试剂中的应用
CN109939080B (zh) * 2019-03-11 2021-03-09 陕西师范大学 基于共轭聚合物的热敏型载药纳米粒子及其制备方法
US11012035B2 (en) 2019-05-15 2021-05-18 Nxp Usa, Inc. Amplifier devices with input transient termination
US11082016B2 (en) 2019-05-15 2021-08-03 Nxp Usa, Inc. Amplifier devices with reflection absorption
CA3154234A1 (en) * 2019-10-14 2021-04-22 Jayant Jagannath Khandare Non-hemolytic compositions and methods of use for recovering disease causing toxic constituents in the blood
CN113189070B (zh) * 2021-04-28 2024-01-16 香港理工大学 一种纳米探针及其制备方法和应用、循环肿瘤细胞的miRNAs的检测系统
CN117607441B (zh) * 2024-01-23 2024-04-12 杭州华得森生物技术有限公司 一种循环肿瘤细胞trop-2免疫显色检测试剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007333225B2 (en) * 2006-12-08 2014-06-12 Massachusetts Institute Of Technology Delivery of nanoparticles and/or agents to cells
TWI577389B (zh) * 2010-10-14 2017-04-11 維里德克斯有限責任公司 使用多專一性捕捉及雞尾酒檢測試劑檢測胰臟病患之循環腫瘤細胞的方法及套組
EP2530125A1 (en) * 2011-05-30 2012-12-05 Total SA Core-shell particles with catalytic activity

Also Published As

Publication number Publication date
CY1123652T1 (el) 2022-03-24
EP3259598A4 (en) 2018-10-10
WO2016132265A2 (en) 2016-08-25
US20180024135A1 (en) 2018-01-25
EP3259598B1 (en) 2020-07-29
CA2976614A1 (en) 2016-08-25
ES2828025T3 (es) 2021-05-25
EP3259598A2 (en) 2017-12-27
US20230408525A1 (en) 2023-12-21
WO2016132265A3 (en) 2017-11-23

Similar Documents

Publication Publication Date Title
PL3259598T3 (pl) Wielofunkcyjne magneto-polimeryczne nanosystemy do szybkiego celowania w krążące komórki nowotworowe, ich izolacji, wykrywania i jednoczesnego obrazowania
EP3286224A4 (en) Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells
IL283733A (en) Methods for treating cancer using activated t cells
IL284172A (en) Diagnostic methods for T-cell therapy
GB2531881B (en) Method of isolating circulating tumor cells
EP3221859A4 (en) Post mortem reconstitution of circulation
EP3207377A4 (en) Circulating tumor cell diagnostics for therapy targeting pd-l1
GB2546793B (en) Radiation imaging system
EP3209202A4 (en) Method to select radiation dosage for tumor treatment based on cellular imaging
HK1246860A1 (zh) 多能量檢測器
EP3114484A4 (en) Biomimetic microfluid device for capturing circulating tumor cells
HK1244848A1 (zh) 使用基因組特異性探針的循環腫瘤和腫瘤幹細胞檢測
HK1260327A1 (zh) 檢測癌症復發的方法
GB2535590B (en) Radiation imaging system
EP3198278A4 (en) Circulating tumor cell diagnostics for identification of resistance to androgen receptor targeted therapies
GB201518583D0 (en) Red Blood cell lysis solution
EP3227922A4 (en) Imaging system for simultaneous imaging and energy harvesting
GB201522223D0 (en) Therapeutic T cells
SG11201610430QA (en) Growth-independent detection of cells
IL243259A0 (en) A device for detecting skin cancer through imaging
EP3286339A4 (en) Oligonucleotide-based probes for detection of circulating tumor cell nucleases
GB2525465B (en) Setting ion detector gain using ion area
GB201403115D0 (en) Red blood cell detection
ZA201708516B (en) Specific photoimmuno-theranostics for detection and elimination of skin cancer cells
GB201512334D0 (en) Methods for selective killing of cancer cells